Batrafen, created in 1954 (Germany), from 2757 sister brands and 17477 competing brands. The Batrafen brand is owned by SANOFI, a company listed in Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. Batrafen is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
SANOFI
(Batrafen)
over 5 years*
EUR 101.49